Bioxytran Inc
(BIXT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 609 | 779 | 1,007 | 986 | 1,058 |
| Operating Income | -609 | -779 | -1,007 | -986 | -1,058 |
| Interest Expense | 21 | 28 | 38 | 49 | 40 |
| Other Income | -32 | 233 | -125 | -94 | -351 |
| Pre-tax Income | -662 | -574 | -1,169 | -1,128 | -1,448 |
| Net Income Continuous | -662 | -574 | -1,169 | -1,128 | -1,448 |
| Minority Interests | 0 | -13 | -22 | -35 | -1 |
| Net Income | $-662 | $-561 | $-1,147 | $-1,093 | $-1,447 |
| EPS Basic Total Ops | 0.00 | 0.00 | N/A | -0.01 | -0.01 |
| EPS Basic Continuous Ops | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Total Ops | 0.00 | 0.00 | N/A | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Before Non-Recurring Items | 0.00 | 0.00 | -0.01 | N/A | N/A |
| EBITDA(a) | $-578 | $-777 | $-1,003 | $-984 | $-707 |